Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study looks at whether bits of tumor DNA in the blood can help check treatment response early in people with solid tumors. It also explores whether this DNA can help find cancer that remains or comes back. Healthy donors age 18 or older can take part.
Earlier detection of disease recurrence will enable greater treatment options and has strong potential to improve patient outcomes. This project is translational and has the potential to lead to future translational research opportunities, including interventional trials in which therapeutic escalation is offered at the early circulating tumor DNA (ctDNA) molecular residual disease (MRD) detection timepoint. Ultimately, the integration of ctDNA into the clinical workflow has the potential to enhance cancer diagnosis, treatment, surveillance, and prognosis, and guide clinical decision-making in this era of personalized precision medicine.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Healthy donors must be age 18 or older.
Who can't join
- Healthy donors younger than 18 cannot take part.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Eligible healthy donors will be at least 18 years of age. Exclusion Criteria: * Healthy donors younger than 18 years of age
Study sites (1)
MO
- Washington University School of Medicine · St Louis, MO 63110Melissa Reimers, M.D. · Study contact · 314-362-7249 · cbumb@wustl.eduMelissa Reimers, M.D. · Principal investigatorPeter Harris, Ph.D. · Sub-investigatorRe-I Chin, M.D. · Sub-investigatorMore trials in St Louis